Jefferies Financial Group initiated coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued a buy ...

StockNews.com upgraded shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) from a sell rating to a hold rating in a ...

Fintel reports that on March 14, 2025, Jefferies initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Buy ...

Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...

The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

Intiva Health proudly announces itself as the parent company of three industry-leading brands: Incredable, Nova Vita, and Gummi World.

Fintel reports that on March 12, 2025, JP Morgan initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Overweight ...

JPMorgan initiated coverage of ANI Pharmaceuticals (ANIP) with an Overweight rating and $85 price target ANI is a specialty pharmaceuticals ...

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...

Fermenta Biotech Limited, amongst the leading manufacturers of Vitamin D3 globally, has been honoured with the ‘Pride of ...

(RTTNews) - While reporting financial results for the fourth quarter on Friday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiated its adjusted earnings for the full-year 2025 ...

Good morning, everyone. Welcome to today's ANI Pharmaceuticals Fourth Quarter 2024 Earnings Results Call. Please note, this call is being recorded. After speakers’ remarks there will be a ...